Is ulcerative colitis associated with survival among older persons with colorectal cancer in the us? A population-based case-control study

Digestive Diseases and Sciences

Volumn 57, Issue 6, 2012, Pages 1647-1651

  Shaukat, Aasma ^a   Salfiti, Nadim I ^a   Virnig, Daniel J ^a   Howard, David H ^b   Sitaraman, Shanthi V ^c   Liff, Jonathan M ^b   Lederle, Frank A ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Colorectal cancer; SEER Medicare; Survival; Ulcerative colitis

Indexed keywords

AGED; ARTICLE; CANCER REGISTRY; CANCER STAGING; COLORECTAL CANCER; COMPARATIVE STUDY; CORRELATION ANALYSIS; EARLY DIAGNOSIS; FEMALE; GERIATRIC PATIENT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICARE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVAL RATE; ULCERATIVE COLITIS; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CAUSE OF DEATH; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; KAPLAN-MEIER ESTIMATE; MALE; MEDICARE; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; RISK ASSESSMENT; SEER PROGRAM; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84864279002     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1966-6     Document Type: Article

References (19)

1. Cotton S, Sharp L, Little J, Cotton S, Sharp L, Little J. The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. Crit Rev Oncog. 1996;7:293-342.
2. Burmer GC, Rabinovitch PS, Haggitt RC, et al. Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. [see comment]. Gastroenterology. 1992;103:1602-1610.
3. Lindberg JO, Stenling RB, Rutegard JN, Lindberg JO, Stenling RB, Rutegard JN. Eighteen-year surveillance of dysplasia-associated lesion in ulcerative colitis. Endoscopy. 2000;32:359-360. (Pubitemid 30175453)
4. Odze RD, Odze RD. Adenomas and adenoma-like dalms in chronic ulcerative colitis: a clinical, pathological, and molecular review. Am J Gastroenterol. 1999;94:1746-1750. (Pubitemid 29315881)
5. Fogt F, Alsaigh N, Fogt F, Alsaigh N. Polypoid dysplasias in ulcerative colitis and sporadic adenomas: genetic approach to the differential diagnosis (review). Oncol Rep. 1999;6:721-725.
6. Blackstone MO, Riddell RH, Rogers BH, et al. Dysplasia-asso-ciated lesion or mass (dalm) detected by colonoscopy in longstanding ulcerative colitis: an indication for colectomy. Gastroenterology. 1981;80:366-374. (Pubitemid 11217532)
7. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48: 526-535. (Pubitemid 32234798)
8. Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflammatory Bowel Diseases. 2005;11:314-321. (Pubitemid 40439686)
9. Shaukat A, Virnig DJ, Salfiti NI, Howard DH, Sitaraman SV, Liff JM (2011) Is inflammatory bowel disease an important risk factor among older persons with colorectal cancer in the United States? A population-based case-control study. Dig Dis Sci. 56:2378-2383. doi:10.1007/s10620-011-1632-z.
10. Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. [see comment]. Gut. 1998;42:711-714. (Pubitemid 28261062)
11. Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993;105:418-424. (Pubitemid 23213526)
12. Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, Loftus EV Jr. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:335-342. (Pubitemid 43343890)
13. Lakatos L, Mester G, Erdelyi Z, et al. Risk factors for ulcerative colitis-associated colorectal cancer in a hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflammatory bowel diseases. 2006;12:205-211.
14. Jensen AB, Larsen M, Gislum M, et al. Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. Am J Gastroenterol. 2006;101:1283-1287. (Pubitemid 43829994)
15. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the seer-medicare data: CONTENT, research applications, and generalizability to the United States elderly population. Med Care. 2002;40:IV-3-IV-18.
16. Kiran RP, Khoury W, Church JM, Lavery IC, Fazio VW, Remzi FH. Colorectal cancer complicating inflammatory bowel disease: Similarities and differences between crohn's and ulcerative colitis based on three decades of experience. Ann Surg. 2010;252: 330-335.
17. Lutgens MW, Vleggaar FP, Schipper ME, et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut. 2008;57:1246-1251.
18. Larsen M, Mose H, Gislum M, et al. Survival after colorectal cancer in patients with Crohn's disease: a nationwide population-based danish follow-up study. Am J Gastroenterol. 2007;102: 163-167. (Pubitemid 46072057)
19. Shu X, Ji J, Sundquist J, Sundquist K, Hemminki K. Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden. Inflamm Bowel Dis. 2011;17:816-822.